The Global Non-Small Cell Lung Carcinoma Industry is on a trajectory for significant growth, fueled by a robust Compound Annual Growth Rate (CAGR) of 10% projected from 2023 to 2033. According to market analysts, the market is expected to reach an impressive US$8.25 billion by 2023, and a staggering US$21.40 billion by 2033. This growth …
Tag Archives: Global Non-Small Cell Lung Carcinoma
Global Non-Small Cell Lung Carcinoma Industry is expected to reach a valuation of US$ 21.40 Billion by 2033, Driven by a strong 10% CAGR | FMI
According to market projections, the Global Non-Small Cell Lung Carcinoma Industry is poised for a significant transformation. The market is expected to grow at a robust Compound Annual Growth Rate (CAGR) of 10%, reaching an impressive US$ 8.25 billion in 2023 and an even more astounding US$ 21.40 billion by 2033. Carefully considered insights obtained …